ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells
Ying Yu(Fudan University), Yifei Xing(Union Hospital), Yunxue Li(Union Hospital), Dingheng Lu(Union Hospital), Yarong Song(Union Hospital), Liang Chen(Pingjin Hospital), Bing Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Pu Zhang(Union Hospital), Likun Yang(Union Hospital), Fang Lv(Liaoning Normal University), Lulin Cheng(Union Hospital), Xuexiang Li(Northwestern Polytechnical University)
Cited by 74
Related Papers
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
|Genome Biology|2015|429
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
RETRACTED ARTICLE: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway
|Journal of Experimental & Clinical Cancer Research|2018|118
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115